Sartorius Stedim Biotech Virtual Annual Shareholders' Meeting on March 24, 2021
The health of shareholders and employees is a top priority for Sartorius Stedim Biotech. In view of the ongoing coronavirus pandemic, the Board of Directors has decided to hold the 2021 Annual General Meeting in camera, without the physical presence of shareholders, their proxies, or any other invitees in order to avoid any risk of infection (in accordance with Article 5 of Ordinance No. 2020-321 of March 25, 2020, adapting the rules for meetings and deliberations of the General Meetings as extended and amended by French Ordinance No. 2020-1497 of December 2, 2020). Shareholders and invitees were therefore requested not to physically travel to the venue of the Shareholders Meeting. They were asked to submit a prior vote at distance under the conditions set out in the documentation below.
Here you will find the information and documents that shareholders should have access to, regarding the virtual General Meeting of Shareholders held behind closed doors and via webcast, of Sartorius Stedim Biotech S.A. on March 24, 2021 at 2:00 p.m.
These documents are translated into English only for your convenience. The French originals, which have sole legal force, are available on the French website.
If you have any reason to assume that the documents provided on the website of Sartorius Stedim Biotech S.A. are incomplete, please contact us promptly at asm.ssb@sartorius.com.
Documents
- Annual General Meeting Presentation PDF | 2.2 MB
- Voting Results XLSX | 18.9 KB
- Report of the Shareholders' Meeting PDF | 30.0 KB
1. Information to Shareholders
- 1.1 Notice of the meeting PDF | 239.6 KB
- 1.1 Notice of the meeting BALO PDF | 185.9 KB
- 1.2 Shareholders' convening guide PDF | 1.4 MB
- 1.3 Vote form PDF | 3.3 MB
- 1.4 Request of documents by a shareholder PDF | 68.6 KB
- 1.5 Resolutions PDF | 259.8 KB
2. Documents to be presented to the Annual General Meeting
- 2.1 Group Management Report PDF | 856.1 KB
- 2.2 Management Report of Sartorius Stedim Biotech S.A. PDF | 80.8 KB
- 2.3 Board of Director's Report on Corporate Governance PDF | 313.8 KB
- 2.4 Annual Financial Statements of Sartorius Stedim Biotech S.A. PDF | 93.0 KB
- 2.5 Consolidated financial statements of Sartorius Stedim Biotech Group PDF | 373.4 KB
- 2.6 Statutory auditors' report on the annual financial statement of Sartorius Stedim Biotech S.A. for the financial year closed 31.12.2020 PDF | 49.8 KB
- 2.7 Statutory auditors' report on the consolidated statements of Sartorius Stedim Biotech Group for the financial year closed 31.12.2020 PDF | 61.2 KB
- 2.8 Statutory auditors' report on the information disclosed in accordance with article L. 225-38 of the French Commercial Code PDF | 34.4 KB
- 2.9 Information regarding the Board of Directors’ members PDF | 169.7 KB
- 2.10 Delegations granted to the Board of Directors by the Shareholders’ Meeting PDF | 40.4 KB
- 2.11 Total number of shares and voting rights making up the issued capital PDF | 54.1 KB
- 2.12 Statutory auditors' report on the capital reduction PDF | 144.0 KB